News Glaukos Corporation

Equities

GKOS

US3773221029

Market Closed - Nyse Other stock markets 04:00:02 2024-05-03 pm EDT			5-day change	1st Jan Change
106.5 ^USD	+1.41%		+7.07%	+33.99%

May. 02	Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating	MT
May. 02	JPMorgan Adjusts Price Target on Glaukos to $110 From $108, Maintains Overweight Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating	May. 02	MT
JPMorgan Adjusts Price Target on Glaukos to $110 From $108, Maintains Overweight Rating	May. 02	MT
Glaukos : Q1 2024 Earnings Transcript	May. 02	PU
Truist Raises Glaukos' PT to $125 From $120 After 'Solid' Q1 Beat, Keeps Buy Rating	May. 02	MT
Glaukos : Q1 2024 GAAP to Non-GAAP Recs	May. 02	PU
Glaukos : Q1 2024 Quarterly Summary	May. 02	PU
Earnings Flash (GKOS) GLAUKOS CORPORATION Reports Q1 Revenue $85.6M, vs. Street Est of $79.7M	May. 01	MT
Glaukos: Q1 Earnings Snapshot	May. 01	AQ
Transcript : Glaukos Corporation, Q1 2024 Earnings Call, May 01, 2024	May. 01
Glaukos Announces First Quarter 2024 Financial Results	May. 01	BU
Glaukos Announces the Release of its 2023 Sustainability Report	Apr. 16	BU
Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating	Apr. 11	MT
Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing	Apr. 11	MT
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1	Apr. 10	BU
Sector Update: Health Care Stocks Rise Wednesday Afternoon	Apr. 03	MT
Glaukos Says iDose TR Assigned Permanent J-Code From US Centers for Medicare and Medicaid Services	Apr. 03	MT
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)	Apr. 03	BU
Glaukos Corporation Receives Permanent J-Code for iDose TR (travoprost intracameral implant)	Apr. 03	CI
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	Apr. 01	BU
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry	Mar. 26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Glaukos Corporation

Equities

GKOS

US3773221029

Summary

Filters